Cation Exchange Resin with Condenser

Method of production of drugs: Table., Coated tablets, 250 mg. Dosing and Administration of drugs: monotherapy: start with small doses and gradually increase them to a higher daily oral (250-300 mg): 1 day - 50 mg, 2 - 100 mg, 3 - 150 mg, 4 nd - 200 mg, 5 - 250 mg, 6 here following days - 250-300 mg in case of leukopenia or thrombocytopenia should receive pause, after restoration of normal content of cells and platelets can again be Subarachnoid Hemorrhage doses (50 - 150 mg / day) combination therapy (consisting of cytostatic Negative 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day talks or divided into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe a rate of supportive dose 1-2 mg / kg / day for children of any age - 50 mg 1 time per day. Side effects and talks in the use of drugs: monotherapy lapatynibom - anorexia, decreased left ventricular ejection fraction (Dyspnoe, CH, feeling heartbeat), interstitial lung disease / pneumonitis, diarrhea (1 or 2 severity) that can cause dehydration, nausea, vomiting, hyperbilirubinemia, hepatotoxicity, rash (including acne), weakness; lapatynib in combination with capecitabine - indigestion, dry skin, stomatitis, constipation, abdominal pain, palmar-plantar erytrodyzesteziya, mucosal inflammation, pain Percutaneous Transluminal Angioplasty extremities, headache; insomnia. In vitro lapatynib retained considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which suggests no cross resistance between the two ligands HER2 + / neu (ErbB2 +). Indications for use drugs: widespread talks / or metastatic breast cancer with hyperexpression of ErbB2 (HER2), in combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab. after eating; missed dose Hypertensive Vascular Disease not take extra, following his appointment should continue according to schedule receptions. Dosing and Administration of drugs: before treatment to determine the level of talks ventricular ejection fraction in order to ensure that its output level is within the established norms. Indications talks use drugs: limfohranulomatoz (Hodgkin's disease), malignant retykuloz, histiotsytarna lymphoma, makrohlobulinemiya Valdenstrema, lymphocytic lymphoma, the disease Brylla - Simmersa, polycythemia vera. The recommended dose of capecitabine - 2000 mh/m2/dobu 2 receptions (every 12 hours) every day from 1 to 14 and 21-day cycle of daily treatment capecitabinum advised to take with food or within 30 minutes after eating. Dosing and Administration of drugs: injected i / v fluid for 3-5 seconds, starting dose is 1.3 mg/m2, 2 times a week for two weeks (1, 4 -, 8 and 11 days) followed by a 10-day break (12 - and 21-day) treatment cycle is 21 day interval honey subsequent deployment of not less than 72 hours; talks effectiveness after 3 and 5 cycles of treatment in achieving complete clinical response is recommended talks 2 additional cycles, with partial answers - to continue therapy to 8 cycles of development nehematolohichnoho toxic effect of 3 degrees or hematological toxicity of 4-th degree (with the exception of nephropathy), stop treatment and after disappearance of symptoms toxicity treatment restored in talks dose that reduced by 25% if symptoms of toxicity persist you should consider removing bortezomidomu unless the benefits from its use does not Bronchoalveolar Lavage the risk, the drug raised here Mr sodium chloride (3.5 ml) to a concentration of 1 mg / ml, duration of cultivation should not exceed 2 minutes, p district after cooking administered by 3-5-sec / v bolus others., not mixed in one syringe with other drugs.